Projects
Search from 1158 projects:
1158 Project(s)
PREFER in AF
May 31, 2012Europäische Multinationale Studie zur Prävention von Thromboembolien bei Vorhofflimmern DSE-EAF-01-11 Vorhofflimmern (VHF) ist die häufigste Herzrhythmusstörung im klinischen Alltag, von der ca.1-2% der allgemeinen Bevölkerung betroffen sind.1, 2 Die...
Clinical Studies - May 31, 2012 - Dec 31, 2013
Completed
Project leader: Ammann Peter
Members: Gemperle Michaela
ORSIRO
May 29, 2012Ein randomisierter Vergleich zwischen einem Sirolimus-freisetzenden Koronarstent mit bioderadierbarem Polymer und einem Everolimusbeschichteten Koronarstent mit einem nicht bioresorbierbaren Polymer bei Patienten mit einer koronaren Herzkrankheit, be...
Clinical Studies - May 29, 2012 - May 29, 2016
Completed
Project leader: Weilenmann Daniel
Members: Schefer Mirjam, Schneider Irene
Eine Phase-3-Studie zu BMS-790052 (Daclatasvir) im Vergleich zu Telaprevir in Kombination mit Peginterferon alfa-2a und Ribavirin bei therapienaiven Patienten mit chronischer Hepatitis-C-Infektion
May 21, 2012
Clinical Studies - May 21, 2012 - Dec 31, 2012
Completed
Project leader: Semela David
Members: Sawatzki Mikael, Künzler-Heule Patrizia, Weinmann Sabine
Long-term, prospective, observational, multinational, parallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy - FTY720
May 20, 2012Long-term, prospective, observational, multinational, parallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy Study: FTY720 - 2403
Clinical Studies - May 20, 2012 - Dec 31, 2018
Automatically Closed
Project leader: Müller Stefanie
Prospective, Randomized, Partly Blinded, in Part Placebo-controlled, Multicenter, Dose-finding Trial Exploring Safety, Tolerability and Efficacy of a Topical Resiquimod Gel in Patients With Multiple Actinic Keratosis Lesions
May 19, 2012Purpose: A Dose-Finding Study of Resiquimod Evaluating Safety and Efficacy in Patients with Multiple Actinic Keratosis Lesions
Clinical Studies - May 19, 2012 - Jun 19, 2013
Automatically Closed
Project leader: Anliker Mark
Endosono
May 19, 2012
Clinical Studies - May 19, 2012 - Nov 19, 2012
Completed
Project leader: Hornung René, Bolla Daniele
EVITA-RAID-HF Register
May 14, 2012Evidence based treatment in heart failure (EVITA-HF) mit Teilprojekt Registry analysis of iron deficiency in heart failure (RAID-HF).
Clinical Studies - May 14, 2012 - Dec 31, 2016
Completed
Project leader: Rickli Hans
Members: Maeder Micha, Gall Christian, Gemperle Michaela
Desflurane and its effect on postoperative morbidity and mortality in patients undergoing thoracic surgery: a multicenter randomized trial
May 7, 2012Hintergrund der Studie: Eine Anästhesie für Eingriffe an der Lunge kann entweder mit einem volatilen (wird über die Luftwege appliziert) oder einem intravenösen Anästhetikum (wird über eine Vene verabreicht) durchgeführt werden. Dies wird meistens v...
Clinical Studies - May 7, 2012 - Apr 30, 2015
Completed
Project leader: Filipovic Miodrag
STENTYS Sizing Registry
May 7, 2012The STENTYS Sizing Registry is a multinational post-marketing surveillance registry designed to evaluate large scale safety and reliability of the STENTYS Stents use in routine, worldwide daily practice. This internet-based registry will enroll 5000...
Clinical Studies - May 7, 2012 - Oct 31, 2019
Aborted
Project leader: Weilenmann Daniel
Members: Schneider Irene
Sakrale Neuromodulation bei neurogenen Blasenfunktionsstörungen: Eine randomisierte, placebo-kontrollierte, doppel-blinde klinische Studie
May 3, 2012PatientInnen mit neurologischer Erkrankung leiden oft an Blasensymptomen, die die Lebensqualität stark beeinträchtigen können. Die Prävalenz von neurogenen Blasenfunktionsstörungen ist abhängig von der Art und Dauer der neurologischen Erkrankung und...
Clinical Studies - May 3, 2012 - May 3, 2016
Automatically Closed
Project leader: Engeler Daniel
Members: Meyer Daniel, Abt Dominik, Schaepper Sibylle
Serum and tissue biomarkers in patients with early and advanced-stage renal-cell carcinoma
May 1, 2012Das klarzellige Nierenzellkarzinom (kNZK) ist der häufigste Tumorsubtyp beim Nierenkrebs mit der geringsten Überlebensrate. Die Entwicklung von Nachweisverfahren zur Früherkennung von kNZK, und die Identifikation prädiktiver Biomarker in PatientInnen...
Clinical Studies - May 1, 2012 - Jun 30, 2014
Automatically Closed
Project leader: Jörger Markus
Members: Gillessen Sommer Silke, Rothermundt Christian
OPEN II
Apr 24, 2012Assessment of Long-Term Safety and Efficacy of the STENTYS Paclitaxel-eluting self-expanding stent in coronary bifurcation lesions
Clinical Studies - Apr 24, 2012 - Dec 31, 2018
Completed
Project leader: Weilenmann Daniel
Members: Schefer Mirjam, Schneider Irene
Carboplatin chemotherapy and involved node radiotherapy in stage II A
Apr 24, 2012Testing efficacy and safety of carboplain chemotherapy and involved node Radio Therapy in patients with stage II A/B seminoma.
Clinical Studies - Apr 24, 2012 - Jun 5, 2028
Ongoing
Project leader: Plasswilm Ludwig
Integration of Cetuximab, in combination with local radiotherapy, in perioperative chemotherapy of resectable and locally ad-vanced gastric cancer. A pilot phase I B-trial
Apr 17, 2012Die Langzeitergebnisse beim lokal-fortgeschrittenen Ma-genkarzinom blieben trotz verbesserter Operationsmetho-dik und routinemässiger Anwendung einer „perioperativen“ Chemotherapie (d.h. Chemotherapiebehandlung vor und nach der Operation) schlecht. S...
Clinical Studies - Apr 17, 2012 - Mar 31, 2013
Aborted
Project leader: Köberle Dieter
SAKK 39/10
Apr 11, 2012Patient/innen dieser Studie leiden an einer bösartigen Er-krankung des Knochenmarkes, dem Multiplen Myelom (MM) und die Erkrankung spricht nicht mehr auf die Stan-dardtherapie (Lenalidomid (Revlimid®)/ Dexamethason) an. Nach Therapieversagen sind der...
Clinical Studies - Apr 11, 2012 - Jun 11, 2014
Automatically Closed
Project leader: Hitz Felicitas
Members: Driessen Christoph
Quality Assurance of Prostate Cancer Radiotherapy Guidelines
Apr 5, 2012The aim of our project is the comparison of guidelines for the primary radiotherapy of prostate cancer among institutions in Switzerland. The goal is not the leveling of guidelines, but a neutral description of deviations, which may lead to a critic...
Clinical Studies - Apr 5, 2012 - Apr 5, 2013
Automatically Closed
Project leader: Putora Paul Martin
Members: Plasswilm Ludwig, Horstkemper Ruth
Non-Interventional Cohort Study on the Utilization and Impact of Dual and Triple Therapies Based on Pegylated Interferon for the Treatment of Chronic Hepatitis C
Apr 2, 2012Beurteilung der Wirksamkeit von Kombinationstherapien mit Peginterferon alpha plus Ribavirin und Therapieschemata mit direkt wirkenden antiviralen Substanzen bei CHC-Patienten, die diese Medikamente im Rahmen der klinischen Routinepraxis gemäss den l...
Clinical Studies - Apr 2, 2012 - Nov 30, 2014
Completed
Project leader: Semela David
Members: Borovicka Jan, Frei Remus, Sulz Michael, Sawatzki Mikael, Semadeni Gian-Marco, Künzler-Heule Patrizia, Weinmann Sabine
An International, Multi-Center Study Evaluating the Correlation of IL28B Genotypes with Chronic Hepatitis C Disease Characteristics and Patient Demographics
Apr 2, 2012Korrelation zwischen den Interleukin 28B - (IL28B-) Genotypen rs12979860 (CC vs. TC vs. TT) und rs8099917 (TT vs. GT vs. GG) und CHC-assoziierter Leberfibrose
Clinical Studies - Apr 2, 2012 - May 30, 2014
Completed
Project leader: Semela David
Members: Borovicka Jan, Frei Remus, Sawatzki Mikael, Semadeni Gian-Marco, Sulz Michael, Künzler-Heule Patrizia, Weinmann Sabine
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™
Apr 1, 2012An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™
Clinical Studies - Apr 1, 2012 - Apr 1, 2013
Completed
Project leader: Müller Stefanie
A 32-week, patient- and rater-blinded, randomized, multicenter, parallel-group study to evaluate disease control and safety in patients with relapsing remitting multiple sclerosis transferred from previous treatment with natalizumab to fingolimod (FTY720)
Apr 1, 2012A 32-week, patient- and rater-blinded, randomized, multicenter, parallel-group study to evaluate disease control and safety in patients with relapsing remitting multiple sclerosis transferred from previous treatment with natalizumab to fingolimod (FT...
Clinical Studies - Apr 1, 2012 - Dec 1, 2012
Aborted
Project leader: Müller Stefanie